<DOC>
	<DOCNO>NCT00688454</DOCNO>
	<brief_summary>The study explore efficacy safety lipid-lowering therapy CRESTOR statin-naive patient patient previously unsuccessful statin therapy . This study design investigate dynamic lipid parameter therapy tolerability 8-10 week treatment CRESTOR</brief_summary>
	<brief_title>C-Control : Efficacy Safety Therapy With Rosuvastatin Statin-Naive Statin-Switched Patients</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>Patients hypercholesteremia never treat statin Patient hypercholesteremia treat statin ( rosuvastatin ) adverse effects/insufficient action switch therapy CRESTOR</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2009</verification_date>
	<keyword>Hyperlipidemia</keyword>
	<keyword>Rosuvastatin</keyword>
	<keyword>Efficacy</keyword>
	<keyword>tolerability</keyword>
	<keyword>CRESTOR therapy</keyword>
</DOC>